BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 24210877)

  • 1. The research of nanoparticles as gene vector for tumor gene therapy.
    Sun NF; Liu ZA; Huang WB; Tian AL; Hu SY
    Crit Rev Oncol Hematol; 2014 Mar; 89(3):352-7. PubMed ID: 24210877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcium phosphate nanoparticles: second-generation nonviral vectors in gene therapy.
    Maitra A
    Expert Rev Mol Diagn; 2005 Nov; 5(6):893-905. PubMed ID: 16255631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laboratory formulated magnetic nanoparticles for enhancement of viral gene expression in suspension cell line.
    Bhattarai SR; Kim SY; Jang KY; Lee KC; Yi HK; Lee DY; Kim HY; Hwang PH
    J Virol Methods; 2008 Feb; 147(2):213-8. PubMed ID: 17935796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene delivery using dendrimer-entrapped gold nanoparticles as nonviral vectors.
    Shan Y; Luo T; Peng C; Sheng R; Cao A; Cao X; Shen M; Guo R; Tomás H; Shi X
    Biomaterials; 2012 Apr; 33(10):3025-35. PubMed ID: 22248990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesenchymal stem cells as a novel carrier for targeted delivery of gene in cancer therapy based on nonviral transfection.
    Hu YL; Huang B; Zhang TY; Miao PH; Tang GP; Tabata Y; Gao JQ
    Mol Pharm; 2012 Sep; 9(9):2698-709. PubMed ID: 22862421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The current state of cancer gene therapy and its application in esophageal carcinoma.
    Buskens CJ; Marsman WA; Bosma PJ; van Lanschot JJ
    Dig Surg; 2005; 22(4):222-33. PubMed ID: 16174979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanoparticle-mediated gene delivery.
    Jin S; Leach JC; Ye K
    Methods Mol Biol; 2009; 544():547-57. PubMed ID: 19488722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assembly of polyethylenimine-based magnetic iron oxide vectors: insights into gene delivery.
    Arsianti M; Lim M; Marquis CP; Amal R
    Langmuir; 2010 May; 26(10):7314-26. PubMed ID: 20112951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanoparticles as nonviral gene delivery vectors.
    Ragusa A; García I; Penadés S
    IEEE Trans Nanobioscience; 2007 Dec; 6(4):319-30. PubMed ID: 18217625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal stem cells: a promising targeted-delivery vehicle in cancer gene therapy.
    Hu YL; Fu YH; Tabata Y; Gao JQ
    J Control Release; 2010 Oct; 147(2):154-62. PubMed ID: 20493219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene therapy progress and prospects: magnetic nanoparticle-based gene delivery.
    Dobson J
    Gene Ther; 2006 Feb; 13(4):283-7. PubMed ID: 16462855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic targeting strategies in gene delivery.
    Delyagina E; Li W; Ma N; Steinhoff G
    Nanomedicine (Lond); 2011 Nov; 6(9):1593-604. PubMed ID: 22077463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Viral and non-viral vectors for cancer gene therapy.
    Cristiano RJ
    Anticancer Res; 1998; 18(5A):3241-5. PubMed ID: 9858889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the strategy of using nonviral carriers in cancer gene therapy.
    Sochanik A; Szala S
    Acta Biochim Pol; 1996; 43(2):293-300. PubMed ID: 8862173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of gold nanoparticles in cancer therapy.
    Zhao CT; Liu ZB
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2014 Jun; 36(3):324-9. PubMed ID: 24997828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene therapy progress and prospects: non-viral gene therapy by systemic delivery.
    Li SD; Huang L
    Gene Ther; 2006 Sep; 13(18):1313-9. PubMed ID: 16953249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel hyaluronic acid-chitosan nanoparticles as non-viral gene delivery vectors targeting osteoarthritis.
    Lu HD; Zhao HQ; Wang K; Lv LL
    Int J Pharm; 2011 Nov; 420(2):358-65. PubMed ID: 21911044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progress in developing cationic vectors for non-viral systemic gene therapy against cancer.
    Morille M; Passirani C; Vonarbourg A; Clavreul A; Benoit JP
    Biomaterials; 2008; 29(24-25):3477-96. PubMed ID: 18499247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Current status and prospects of non-viral vector in inner ear gene therapy].
    Sun H; Wu X
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 Dec; 27(23):1339-42. PubMed ID: 24620675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Application of microorganisms as delivery vehicles in cancer gene therapies].
    Łepeta K; Łasica AM; Jagusztyn-Krynicka EK
    Postepy Biochem; 2012; 58(3):314-26. PubMed ID: 23373417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.